Angela M. Cheung

Faculty Member

Accepting Students

Professional Interests

clinical effectiveness, technology assessment / drug utilization, medical decision-making, performance measurement / program evaluation, women’s health (cardiovascular health, osteoporosis, and breast cancer), COVID and long COVID


Angela Cheung is a member of the community providing the groundbreaking perspectives and inspiring contributions that define IHPME.

Other Affiliations

  • Staff, General Internal Medicine
  • Director, Osteoporosis Program
  • Director, Centre of Excellence in Skeletal Health Assessment (CESHA)
  • Senior Scientist, Toronto General Research Institute, University Health Network
  • KY and Betty Ho Chair in Integrative Medicine, University of Toronto
  • Canada Research Chair (Tier 1) in Musculoskeletal and Postmenopausal Health and Professor of Medicine, University of Toronto

Accepting Students

Care transitions in and out of hospital are increasingly the target of health system reform in Canada. Despite the focus on care transitions, few interventions have been found to reduce readmissions or costs. Integrated models of care (IC) are evidence-based […]

Prognostic Factors for First Clinical Fracture in Patients with Primary Osteoporosis: Analyses of Data from the Canadian Database of Osteoporosis and Osteopenia

Published: 2005


CANCOV: The Canadian COVID-19 Prospective Cohort Study

The Canadian COVID-19 Prospective Cohort Study (CANCOV) is a platform observational study that provides a comprehensive evaluation of early to 2-year outcomes in patients with COVID-19 and their family caregivers.

Lead: Angela M. Cheung

Affiliates: Fahad Razak, Amol Verma, Niall D. Ferguson, Melanie Barwick, Neill Adhikari, Teresa To, Christine Soong, Damon C. Scales, Lawrence Robinson, Lauren Lapointe-Shaw, Victoria McCredie, Nick Daneman, Ella Huszti


RECLAIM: Recovering from COVID-19 Lingering Symptoms Adaptive Integrative Medicine Trial

Accepting Students

RECLAIM is an adaptive platform randomized trial comparing the effectiveness of various treatments for lingering symptoms of COVID-19.

Lead: Angela M. Cheung

Affiliates: George A. Tomlinson